News | December 24, 2024
Ikena Oncology and Inmagene Biopharmaceuticals announce agreement for merger
The transaction is expected to result in approximately $175 million to support further development of IMG-007
The transaction is expected to result in approximately $175 million to support further development of IMG-007
Laurus Labs informs that Eight Roads Ventures and F-Prime Capital (Investors) have together invested Rs. 120 crores in Laurus Bio
The offer price is approximately 4.32% below the closing price of the Merck common stock on November 11, 2024
Q2 FY25 Total Income was at Rs. 85.4 crore
Hospital business revenues increase 13.9% to Rs. 1,655 crore
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
MedGenome reaffirms its commitment to broaden access to quality and affordable genetic solutions for all
The share subscription agreements are being executed at a pre-money equity value of US$ 1.65 billion
US$ 800 million senior secured notes, the largest high yield debut USD bond issuance from India in the last 10 years
The Notes shall not be offered or sold in India
Subscribe To Our Newsletter & Stay Updated
